Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Colorectal Neoplasms

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 139 articles:
HTML format
Text format



Single Articles


    October 2019
  1. ISHIKAWA K, Kawano Y, Arihara Y, Kubo T, et al
    BH3 profiling discriminates the antiapoptotic status of 5fluorouracilresistant colon cancer cells.
    Oncol Rep. 2019 Oct 15. doi: 10.3892/or.2019.7373.
    PubMed     Text format     Abstract available


  2. LV Y, Xie B, Bai B, Shan L, et al
    Weighted gene coexpression analysis indicates that PLAGL2 and POFUT1 are related to the differential features of proximal and distal colorectal cancer.
    Oncol Rep. 2019 Oct 14. doi: 10.3892/or.2019.7368.
    PubMed     Text format     Abstract available


  3. WU B, Sun D, Ma L, Deng Y, et al
    Exosomes isolated from CAPS1overexpressing colorectal cancer cells promote cell migration.
    Oncol Rep. 2019 Oct 9. doi: 10.3892/or.2019.7361.
    PubMed     Text format     Abstract available


  4. NEGRI F, Bozzetti C, Pedrazzi G, Azzoni C, et al
    High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer.
    Oncol Rep. 2019 Oct 1. doi: 10.3892/or.2019.7349.
    PubMed     Text format     Abstract available


    September 2019
  5. DHO SH, Cho EH, Lee JY, Lee SY, et al
    A novel therapeutic antiCD55 monoclonal antibody inhibits the proliferation and metastasis of colorectal cancer cells.
    Oncol Rep. 2019 Sep 26. doi: 10.3892/or.2019.7337.
    PubMed     Text format     Abstract available


  6. RUAN GT, Gong YZ, Liao XW, Wang S, et al
    Diagnostic and prognostic values of CXC motif chemokine ligand 3 in patients with colon cancer.
    Oncol Rep. 2019 Sep 19. doi: 10.3892/or.2019.7326.
    PubMed     Text format     Abstract available


  7. SHU W, Liu G, Dai Y, Feng A, et al
    The oncogenic role of NKAP in the growth and invasion of colon cancer cells.
    Oncol Rep. 2019 Sep 18. doi: 10.3892/or.2019.7322.
    PubMed     Text format     Abstract available


  8. JIANG X, Shen TY, Lu H, Shi C, et al
    Clinical significance and biological role of KLF17 as a tumour suppressor in colorectal cancer.
    Oncol Rep. 2019 Sep 18. doi: 10.3892/or.2019.7324.
    PubMed     Text format     Abstract available


  9. LI Y, Xi Y, Zhu G, Jia J, et al
    Downregulated IGFBP7 facilitates liver metastasis by modulating epithelialmesenchymal transition in colon cancer.
    Oncol Rep. 2019 Sep 6. doi: 10.3892/or.2019.7303.
    PubMed     Text format     Abstract available


  10. SAWADA R, Arai Y, Sagawa Y, Nagata Y, et al
    High blood levels of soluble OX40 (CD134), an immune costimulatory molecule, indicate reduced survival in patients with advanced colorectal cancer.
    Oncol Rep. 2019 Sep 6. doi: 10.3892/or.2019.7304.
    PubMed     Text format     Abstract available


    August 2019
  11. HONG HK, Pyo DH, Kim TW, Yun NH, et al
    Efficient primary culture model of patientderived tumor cells from colorectal cancer using a Rhoassociated protein kinase inhibitor and feeder cells.
    Oncol Rep. 2019 Aug 20. doi: 10.3892/or.2019.7285.
    PubMed     Text format     Abstract available


  12. LI J, He J, Wang Y, Shu Y, et al
    SMC1 promotes proliferation and inhibits apoptosis through the NFkappaB signaling pathway in colorectal cancer.
    Oncol Rep. 2019 Aug 8. doi: 10.3892/or.2019.7273.
    PubMed     Text format     Abstract available


  13. GU J, Wang L, Li T, Tang S, et al
    Role and mechanism of organic cation transporter 3 in oxaliplatin treatment of colon cancer in vitro and in vivo.
    Oncol Rep. 2019 Aug 7. doi: 10.3892/or.2019.7267.
    PubMed     Text format     Abstract available


  14. TONG J, Shen Y, Chen X, Wang R, et al
    FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression.
    Oncol Rep. 2019 Aug 2. doi: 10.3892/or.2019.7259.
    PubMed     Text format     Abstract available


    July 2019
  15. TANAKA E, Miyakawa Y, Kishikawa T, Seimiya T, et al
    Expression of circular RNA CDR1AS in colon cancer cells increases cell surface PDL1 protein levels.
    Oncol Rep. 2019 Jul 19. doi: 10.3892/or.2019.7244.
    PubMed     Text format     Abstract available


  16. LI H, Lai Z, Yang H, Peng J, et al
    Hedyotis diffusa Willd. inhibits VEGFCmediated lymphangiogenesis in colorectal cancer via multiple signaling pathways.
    Oncol Rep. 2019 Jul 5. doi: 10.3892/or.2019.7223.
    PubMed     Text format     Abstract available


  17. CHEN Y, Yang Z, Wu D, Min Z, et al
    Upregulation of interleukin17F in colorectal cancer promotes tumor invasion by inducing epithelialmesenchymal transition.
    Oncol Rep. 2019 Jul 4. doi: 10.3892/or.2019.7220.
    PubMed     Text format     Abstract available


    May 2019
  18. XIONG W, Wang X, Cai X, Xiong W, et al
    Identification of tRNAderived fragments in colon cancer by comprehensive small RNA sequencing.
    Oncol Rep. 2019 May 31. doi: 10.3892/or.2019.7178.
    PubMed     Text format     Abstract available


  19. WAN Z, Chai R, Yuan H, Chen B, et al
    MEIS2 promotes cell migration and invasion in colorectal cancer.
    Oncol Rep. 2019 May 15. doi: 10.3892/or.2019.7161.
    PubMed     Text format     Abstract available


  20. YIN J, Qi W, Ji CG, Zhang DX, et al
    Small RNA sequencing revealed aberrant piRNA expression profiles in colorectal cancer.
    Oncol Rep. 2019 May 13. doi: 10.3892/or.2019.7158.
    PubMed     Text format     Abstract available


  21. KITAGAWA H, Kitajima Y, Kai K, Komukai S, et al
    Predictive value of the ratio of 8hydroxydeoxyguanosine levels between cancerous and normal tissues in patients with stage II/III colorectal cancer.
    Oncol Rep. 2019;41:3041-3050.
    PubMed     Text format     Abstract available


  22. QIAN W, Feng Y, Li J, Peng W, et al
    Construction of ceRNA networks reveals differences between distal and proximal colon cancers.
    Oncol Rep. 2019;41:3027-3040.
    PubMed     Text format     Abstract available


  23. BANH T, Snoke D, Cole RM, Angelotti A, et al
    Higher tumor mass and lower adipose mass are associated with colon26 adenocarcinomainduced cachexia in male, female and ovariectomized mice.
    Oncol Rep. 2019;41:2909-2918.
    PubMed     Text format     Abstract available


  24. WANG JQ, Tang Y, Li QS, Xiao M, et al
    PARG regulates the proliferation and differentiation of DCs and T cells via PARP/NFkappaB in tumour metastases of colon carcinoma.
    Oncol Rep. 2019;41:2657-2666.
    PubMed     Text format     Abstract available


    April 2019
  25. YAO Y, Rao C, Zheng G, Wang S, et al
    Luteolin suppresses colorectal cancer cell metastasis via regulation of the miR384/pleiotrophin axis.
    Oncol Rep. 2019 Apr 24. doi: 10.3892/or.2019.7136.
    PubMed     Text format     Abstract available


  26. SHIRATORI H, Kawai K, Hata K, Tanaka T, et al
    The combination of temsirolimus and chloroquine increases radiosensitivity in colorectal cancer cells.
    Oncol Rep. 2019 Apr 23. doi: 10.3892/or.2019.7134.
    PubMed     Text format     Abstract available


  27. JIANG J, Li Y, Jiang Z
    Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/beta-catenin signaling pathway.
    Oncol Rep. 2019 Apr 17. doi: 10.3892/or.2019.7126.
    PubMed     Text format     Abstract available


  28. XU C, Yu X, Zhu Y, Cai Z, et al
    Overexpression of calpain1 predicts poor outcome in patients with colorectal cancer and promotes tumor cell progression associated with downregulation of FLNA.
    Oncol Rep. 2019 Apr 16. doi: 10.3892/or.2019.7121.
    PubMed     Text format     Abstract available


  29. ZHANG H, Song Y, Yang C, Wu X, et al
    Overexpression of lncRNA TUSC7 reduces cell migration and invasion in colorectal cancer.
    Oncol Rep. 2019 Apr 9. doi: 10.3892/or.2019.7106.
    PubMed     Text format     Abstract available


    March 2019
  30. CHENG Z, Shao X, Xu M, Wang J, et al
    Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer.
    Oncol Rep. 2019 Mar 15. doi: 10.3892/or.2019.7071.
    PubMed     Text format     Abstract available


  31. ZHANG T, Liu L, Lai W, Zeng Y, et al
    Interaction with tumorassociated macrophages promotes PRL3induced invasion of colorectal cancer cells via MAPK pathwayinduced EMT and NFkappaB signalinginduced angiogenesis.
    Oncol Rep. 2019 Mar 7. doi: 10.3892/or.2019.7049.
    PubMed     Text format     Abstract available


    February 2019
  32. NAGASU S, Sudo T, Kinugasa T, Yomoda T, et al
    Yboxbinding protein 1 inhibits apoptosis and upregulates EGFR in colon cancer.
    Oncol Rep. 2019 Feb 28. doi: 10.3892/or.2019.7038.
    PubMed     Text format     Abstract available


  33. XU J, Qian J, Zhang W, Chen E, et al
    LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL6 and TNFalpha.
    Oncol Rep. 2019 Feb 26. doi: 10.3892/or.2019.7034.
    PubMed     Text format     Abstract available


  34. JIANG Y, Cai Y, Shao W, Li F, et al
    MicroRNA144 suppresses aggressive phenotypes of tumor cells by targeting ANO1 in colorectal cancer.
    Oncol Rep. 2019 Feb 21. doi: 10.3892/or.2019.7025.
    PubMed     Text format     Abstract available


  35. ALCANTARA KMM, Garcia RL
    MicroRNA92a promotes cell proliferation, migration and survival by directly targeting the tumor suppressor gene NF2 in colorectal and lung cancer cells.
    Oncol Rep. 2019 Feb 19. doi: 10.3892/or.2019.7020.
    PubMed     Text format     Abstract available


    January 2019
  36. LV Z, He K, Shi L, Shi K, et al
    Interaction between C2ORF68 and HuR in human colorectal cancer.
    Oncol Rep. 2019 Jan 21. doi: 10.3892/or.2019.6973.
    PubMed     Text format     Abstract available


  37. TIAN W, Du Y, Ma Y, Zhang B, et al
    miR663aTTC22V1 axis inhibits colon cancer metastasis.
    Oncol Rep. 2019 Jan 16. doi: 10.3892/or.2019.6969.
    PubMed     Text format     Abstract available


    December 2018
  38. GUO L, Ma L, Liu C, Lei Y, et al
    ERp29 counteracts the suppression of malignancy mediated by endoplasmic reticulum stress and promotes the metastasis of colorectal cancer.
    Oncol Rep. 2018 Dec 19. doi: 10.3892/or.2018.6943.
    PubMed     Text format     Abstract available


  39. RYU TY, Kim K, Son MY, Min JK, et al
    Downregulation of PRMT1, a histone arginine methyltransferase, by sodium propionate induces cell apoptosis in colon cancer.
    Oncol Rep. 2018 Dec 18. doi: 10.3892/or.2018.6938.
    PubMed     Text format     Abstract available


  40. LI N, Li D, Du Y, Su C, et al
    Overexpressed PLAGL2 transcriptionally activates Wnt6 and promotes cancer development in colorectal cancer.
    Oncol Rep. 2018 Dec 7. doi: 10.3892/or.2018.6914.
    PubMed     Text format     Abstract available


    November 2018
  41. MARQUEZ J, Kratchmarova I, Akimov V, Unda F, et al
    NADH dehydrogenase complex I is overexpressed in incipient metastatic murine colon cancer cells.
    Oncol Rep. 2018 Nov 27. doi: 10.3892/or.2018.6892.
    PubMed     Text format     Abstract available


  42. KITAMURA H, Takemura H, Minamoto T
    Tumor p16INK4 gene expression and prognosis in colorectal cancer.
    Oncol Rep. 2018 Nov 26. doi: 10.3892/or.2018.6884.
    PubMed     Text format     Abstract available


  43. CHEN Y, Liu Y, Zhou Y, You H, et al
    Molecular mechanism of LKB1 in the invasion and metastasis of colorectal cancer.
    Oncol Rep. 2018 Nov 21. doi: 10.3892/or.2018.6877.
    PubMed     Text format     Abstract available


  44. MA Y, Chen Y, Lin C, Hu G, et al
    Biological functions and clinical significance of the newly identified long noncoding RNA RP185F18.6 in colorectal cancer.
    Oncol Rep. 2018;40:2648-2658.
    PubMed     Text format     Abstract available


  45. AKAGI J, Baba H
    Hydrogen gas restores exhausted CD8+ T cells in patients with advanced colorectal cancer to improve prognosis.
    Oncol Rep. 2018 Nov 1. doi: 10.3892/or.2018.6841.
    PubMed     Text format     Abstract available


  46. ZHANG T, Guo J, Gu J, Wang Z, et al
    Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Oncol Rep. 2018 Nov 1. doi: 10.3892/or.2018.6840.
    PubMed     Text format     Abstract available


    October 2018
  47. AI X, Lei Q, Shen X, Li J, et al
    Long noncoding RNA ENST00000547547 inhibits cell proliferation, invasion and migration in colorectal cancer cells.
    Oncol Rep. 2018 Oct 31. doi: 10.3892/or.2018.6834.
    PubMed     Text format     Abstract available


  48. TANG B, Liang W, Liao Y, Li Z, et al
    PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway.
    Oncol Rep. 2018 Oct 25. doi: 10.3892/or.2018.6825.
    PubMed     Text format     Abstract available


  49. MUN JG, Kee JY, Han YH, Lee S, et al
    Galla Rhois water extract inhibits lung metastasis by inducing AMPKmediated apoptosis and suppressing metastatic properties of colorectal cancer cells.
    Oncol Rep. 2018 Oct 22. doi: 10.3892/or.2018.6812.
    PubMed     Text format     Abstract available


  50. ZHANG Z, Zhong X, Xiao Y, Chen C, et al
    MicroRNA-296 inhibits colorectal cancer cell growth and enhances apoptosis by targeting ARRB1-mediated AKT activation.
    Oncol Rep. 2018 Oct 18. doi: 10.3892/or.2018.6806.
    PubMed     Text format     Abstract available


  51. DING L, Gu H, Lan Z, Lei Q, et al
    Downregulation of cyclooxygenase1 stimulates mitochondrial apoptosis through the NFkappaB signaling pathway in colorectal cancer cells.
    Oncol Rep. 2018 Oct 12. doi: 10.3892/or.2018.6785.
    PubMed     Text format     Abstract available


  52. WU J, Zhao R, Lin J, Liu B, et al
    Integrin beta4 reduces DNA damageinduced p53 activation in colorectal cancer.
    Oncol Rep. 2018;40:2183-2192.
    PubMed     Text format     Abstract available


  53. LIU BS, Xia HW, Zhou S, Liu Q, et al
    Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cells.
    Oncol Rep. 2018;40:2171-2182.
    PubMed     Text format     Abstract available


  54. QIAO P, Li S, Zhang H, Yao L, et al
    Farnesoid X receptor inhibits proliferation of human colorectal cancer cells via the miR135A1/CCNG2 signaling pathway.
    Oncol Rep. 2018;40:2067-2078.
    PubMed     Text format     Abstract available


  55. ALSAMMAN K, El-Masry OS
    Staurosporine alleviates cisplatin chemoresistance in human cancer cell models by suppressing the induction of SQSTM1/p62.
    Oncol Rep. 2018;40:2157-2162.
    PubMed     Text format     Abstract available


  56. WEI HT, Guo EN, Liao XW, Chen LS, et al
    Genomescale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
    Oncol Rep. 2018;40:1947-1958.
    PubMed     Text format     Abstract available


    September 2018
  57. CHEN Y, Huang Y, Lu X, Wang G, et al
    Antitumor effects of the silencing of programmed cell death ligand 1 in colorectal cancer via immunoregulation.
    Oncol Rep. 2018 Sep 26. doi: 10.3892/or.2018.6738.
    PubMed     Text format     Abstract available


  58. XIE B, Zhao R, Bai B, Wu Y, et al
    Identification of key tumorigenesisrelated genes and their microRNAs in colon cancer.
    Oncol Rep. 2018 Sep 21. doi: 10.3892/or.2018.6726.
    PubMed     Text format     Abstract available


  59. JANG SW, Park WJ, Min H, Kwon TK, et al
    Altered mRNA expression levels of the major components of sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer.
    Oncol Rep. 2018 Sep 18. doi: 10.3892/or.2018.6712.
    PubMed     Text format     Abstract available


  60. LIN WC, Wang WH, Lin YH, Leu JD, et al
    Synergistic effects of tetrandrine combined with ionizing radiation on a murine colorectal carcinomabearing mouse model.
    Oncol Rep. 2018;40:1390-1400.
    PubMed     Text format     Abstract available


    August 2018
  61. ZHOU N, Sun Z, Li N, Ge Y, et al
    miR197 promotes the invasion and migration of colorectal cancer by targeting insulinlike growth factorbinding protein 3.
    Oncol Rep. 2018 Aug 10. doi: 10.3892/or.2018.6640.
    PubMed     Text format     Abstract available


  62. LU J, Zhang L, Zhou H, Du Z, et al
    Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
    Oncol Rep. 2018;40:887-894.
    PubMed     Text format     Abstract available


  63. PENG W, Tan S, Xu Y, Wang L, et al
    LCMS/MS metabolome analysis detects the changes in the lipid metabolic profiles of dMMR and pMMR cells.
    Oncol Rep. 2018;40:1026-1034.
    PubMed     Text format     Abstract available


    July 2018
  64. NIE S, Huang Y, Shi M, Qian X, et al
    Protective role of ABCG2 against oxidative stress in colorectal cancer and its potential underlying mechanism.
    Oncol Rep. 2018 Jul 24. doi: 10.3892/or.2018.6594.
    PubMed     Text format     Abstract available


  65. JI B, Feng Y, Sun Y, Ji D, et al
    GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelialmesenchymal transition through PI3K/AKT signaling activation.
    Oncol Rep. 2018 Jul 20. doi: 10.3892/or.2018.6582.
    PubMed     Text format     Abstract available


  66. CHENG K, Zhao Z, Wang G, Wang J, et al
    lncRNA GAS5 inhibits colorectal cancer cell proliferation via the miR1825p/FOXO3a axis.
    Oncol Rep. 2018 Jul 20. doi: 10.3892/or.2018.6584.
    PubMed     Text format     Abstract available


  67. LI JW, Huang CZ, Li JH, Yuan JH, et al
    Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer.
    Oncol Rep. 2018 Jul 17. doi: 10.3892/or.2018.6581.
    PubMed     Text format     Abstract available


  68. YANG X, Liu W, Xu X, Zhu J, et al
    Downregulation of long noncoding RNA UCA1 enhances the radiosensitivity and inhibits migration via suppression of epithelialmesenchymal transition in colorectal cancer cells.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6573.
    PubMed     Text format     Abstract available


  69. JIANG T, Li H, Jiang R, Li H, et al
    Pin2/TRF1binding protein X1 inhibits colorectal cancer cell migration and invasion in vitro and metastasis in vivo via the nuclear factorkappaB signaling pathway.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6570.
    PubMed     Text format     Abstract available


  70. IIDA M, Hazama S, Tsunedomi R, Tanaka H, et al
    Overexpression of miR221 and miR222 in the cancer stroma is associated with malignant potential in colorectal cancer.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6575.
    PubMed     Text format     Abstract available


  71. SONG J, Wang L, Ma Q, Yang Y, et al
    Let7i5p inhibits the proliferation and metastasis of colon cancer cells by targeting kallikreinrelated peptidase 6.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6577.
    PubMed     Text format     Abstract available


  72. LI Y, Xin S, Wu H, Xing C, et al
    High expression of microRNA31 and its host gene LOC554202 predict favorable outcomes in patients with colorectal cancer treated with oxaliplatin.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6571.
    PubMed     Text format     Abstract available


  73. FENG Y, Dong YW, Song YN, Xiao JH, et al
    MicroRNA449a is a potential predictor of colitisassociated colorectal cancer progression.
    Oncol Rep. 2018 Jul 12. doi: 10.3892/or.2018.6566.
    PubMed     Text format     Abstract available


  74. ZHANG H, Deng Z, Zhang D, Li H, et al
    High expression of leucinerich repeatcontaining 8A is indicative of a worse outcome of colon cancer patients by enhancing cancer cell growth and metastasis.
    Oncol Rep. 2018 Jul 10. doi: 10.3892/or.2018.6556.
    PubMed     Text format     Abstract available


  75. XU Y, Liu X, Zhang H, Zhu Z, et al
    Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/beta-catenin signaling pathway in colorectal cancer.
    Oncol Rep. 2018 Jul 2. doi: 10.3892/or.2018.6539.
    PubMed     Text format     Abstract available


  76. BI C, Jiang B
    Downregulation of RPN2 induces apoptosis and inhibits migration and invasion in colon carcinoma.
    Oncol Rep. 2018;40:283-293.
    PubMed     Text format     Abstract available


    June 2018
  77. LIU M, Zhang X, Cai J, Li Y, et al
    Downregulation of TRIM58 expression is associated with a poor patient outcome and enhances colorectal cancer cell invasion.
    Oncol Rep. 2018 Jun 26. doi: 10.3892/or.2018.6525.
    PubMed     Text format     Abstract available


  78. GUO Y, Wang M, Jia X, Zhu H, et al
    Wnt signaling pathway upregulates DNMT1 to trigger NHERF1 promoter hypermethylation in colon cancer.
    Oncol Rep. 2018 Jun 14. doi: 10.3892/or.2018.6494.
    PubMed     Text format     Abstract available


  79. ZHANG Y, Wang S, Qian W, Ji D, et al
    uc.338 targets p21 and cyclin D1 via PI3K/AKT pathway activation to promote cell proliferation in colorectal cancer.
    Oncol Rep. 2018 Jun 7. doi: 10.3892/or.2018.6480.
    PubMed     Text format     Abstract available


  80. NIKOLOUZAKIS TK, Vassilopoulou L, Fragkiadaki P, Mariolis Sapsakos T, et al
    Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review).
    Oncol Rep. 2018;39:2455-2472.
    PubMed     Text format     Abstract available


    May 2018
  81. TAMURA S, Isobe T, Ariyama H, Nakano M, et al
    Ecadherin regulates proliferation of colorectal cancer stem cells through NANOG.
    Oncol Rep. 2018 May 24. doi: 10.3892/or.2018.6464.
    PubMed     Text format     Abstract available


  82. ZHU D, Sun Y, Zhang D, Dong M, et al
    miR1 inhibits the progression of colon cancer by regulating the expression of vascular endothelial growth factor.
    Oncol Rep. 2018 May 24. doi: 10.3892/or.2018.6463.
    PubMed     Text format     Abstract available


  83. MENG Q, Chen Y, Lian B, Shang Y, et al
    miR218 promotes apoptosis of SW1417 human colon cancer cells by targeting cFLIP.
    Oncol Rep. 2018 May 23. doi: 10.3892/or.2018.6460.
    PubMed     Text format     Abstract available


  84. ALQURASHI N, Hashimi SM, Alowaidi F, Ivanovski S, et al
    Dual mTOR/PI3K inhibitor NVPBEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4EBP1.
    Oncol Rep. 2018 May 22. doi: 10.3892/or.2018.6457.
    PubMed     Text format     Abstract available


  85. CUI X, Wang G, Shen W, Huang Z, et al
    Lysyl oxidase-like 2 is highly expressed in colorectal cancer cells and promotes the development of colorectal cancer.
    Oncol Rep. 2018 May 21. doi: 10.3892/or.2018.6452.
    PubMed     Text format     Abstract available


  86. ZHENG LZ, Chen SZ
    shRNAinduced knockdown of the SPERT gene inhibits proliferation and promotes apoptosis of human colorectal cancer RKO cells.
    Oncol Rep. 2018 May 21. doi: 10.3892/or.2018.6455.
    PubMed     Text format     Abstract available


  87. LI J, Xu J, Yan X, Jin K, et al
    MicroRNA-485 plays tumour-suppressive roles in colorectal cancer by directly targeting GAB2.
    Oncol Rep. 2018 May 17. doi: 10.3892/or.2018.6449.
    PubMed     Text format     Abstract available


  88. YANG H, Wang S, Kang YJ, Wang C, et al
    Long non-coding RNA SNHG1 predicts a poor prognosis and promotes colon cancer tumorigenesis.
    Oncol Rep. 2018 May 2. doi: 10.3892/or.2018.6412.
    PubMed     Text format     Abstract available


  89. MAO L, Chen Q, Gong K, Xu X, et al
    Berberine decelerates glucose metabolism via suppression of mTORdependent HIF1alpha protein synthesis in colon cancer cells.
    Oncol Rep. 2018;39:2436-2442.
    PubMed     Text format     Abstract available


  90. YU Y, Peng K, Li H, Zhuang R, et al
    SP1 upregulated FoxO3a promotes tumor progression in colorectal cancer.
    Oncol Rep. 2018;39:2235-2242.
    PubMed     Text format     Abstract available


  91. XING Y, Zhao Z, Zhu Y, Zhao L, et al
    Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
    Oncol Rep. 2018;39:2365-2375.
    PubMed     Text format     Abstract available


  92. LI K, Guo J, Wu Y, Jin D, et al
    Suppression of YAP by DDP disrupts colon tumor progression.
    Oncol Rep. 2018;39:2114-2126.
    PubMed     Text format     Abstract available


  93. ZHANG Z, Wang S, Ji D, Qian W, et al
    Construction of a ceRNA network reveals potential lncRNA biomarkers in rectal adenocarcinoma.
    Oncol Rep. 2018;39:2101-2113.
    PubMed     Text format     Abstract available


    April 2018
  94. LI C, Du X, Xia S, Chen L, et al
    MicroRNA-150 inhibits the proliferation and metastasis potential of colorectal cancer cells by targeting iASPP.
    Oncol Rep. 2018 Apr 30. doi: 10.3892/or.2018.6406.
    PubMed     Text format     Abstract available


  95. FUJINO S, Kinugasa T, Sudo T, Mizobe T, et al
    Mina53 nuclear localization is an important indicator of prognosis in patients with colorectal cancer after adjuvant chemotherapy.
    Oncol Rep. 2018 Apr 30. doi: 10.3892/or.2018.6407.
    PubMed     Text format     Abstract available


  96. TERASAKI M, Mima M, Kudoh S, Endo T, et al
    Glycine and succinic acid are effective indicators of the suppression of epithelial-mesenchymal transition by fucoxanthinol in colorectal cancer stem-like cells.
    Oncol Rep. 2018 Apr 24. doi: 10.3892/or.2018.6398.
    PubMed     Text format     Abstract available


  97. ALOWAIDI F, Hashimi SM, Alqurashi N, Alhulais R, et al
    Assessing stemness and proliferation properties of the newly established colon cancer 'stem' cell line, CSC480 and novel approaches to identify dormant cancer cells.
    Oncol Rep. 2018 Apr 23. doi: 10.3892/or.2018.6392.
    PubMed     Text format     Abstract available


  98. CHEN S, Zhang L, Su Y, Zhang X, et al
    Screening potential biomarkers for colorectal cancer based on circular RNA chips.
    Oncol Rep. 2018 Apr 16. doi: 10.3892/or.2018.6372.
    PubMed     Text format     Abstract available


  99. JEONG D, Kim H, Kim D, Ban S, et al
    Protein kinase, membraneassociated tyrosine/threonine 1 is associated with the progression of colorectal cancer.
    Oncol Rep. 2018 Apr 13. doi: 10.3892/or.2018.6371.
    PubMed     Text format     Abstract available


  100. BENEDICTO A, Romayor I, Arteta B
    CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver.
    Oncol Rep. 2018;39:2022-2030.
    PubMed     Text format     Abstract available


  101. PARK JH, Lee JM, Lee EJ, Kim DJ, et al
    Kynurenine promotes the goblet cell differentiation of HT-29 colon carcinoma cells by modulating Wnt, Notch and AhR signals.
    Oncol Rep. 2018;39:1930-1938.
    PubMed     Text format     Abstract available


    March 2018
  102. REN W, Wang T, He X, Zhang Q, et al
    betaarrestin2 promotes 5FUinduced apoptosis via the NFkappaB pathway in colorectal cancer.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6340.
    PubMed     Text format     Abstract available


  103. LIU W, Li L, Ye H, Tao H, et al
    Role of COL6A3 in colorectal cancer.
    Oncol Rep. 2018 Mar 23. doi: 10.3892/or.2018.6331.
    PubMed     Text format     Abstract available


  104. PAN Y, Sun H, Hu X, He B, et al
    The inhibitory role of miR4855p in colorectal cancer proliferation and invasion via targeting of CD147.
    Oncol Rep. 2018 Mar 12. doi: 10.3892/or.2018.6309.
    PubMed     Text format     Abstract available


  105. QI C, Chen Y, Zhou Y, Huang X, et al
    Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Oncol Rep. 2018 Mar 8. doi: 10.3892/or.2018.6303.
    PubMed     Text format     Abstract available


  106. FUJINO S, Miyoshi N, Ohue M, Takahashi Y, et al
    Plateletderived growth factor receptorbeta gene expression relates to recurrence in colorectal cancer.
    Oncol Rep. 2018 Mar 1. doi: 10.3892/or.2018.6290.
    PubMed     Text format     Abstract available


  107. PARK HS, Kim BC, Yeo HY, Kim KH, et al
    Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer.
    Oncol Rep. 2018 Mar 1. doi: 10.3892/or.2018.6287.
    PubMed     Text format     Abstract available


  108. KANEKIYO S, Hazama S, Takenouchi H, Nakajima M, et al
    IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides.
    Oncol Rep. 2018 Mar 1. doi: 10.3892/or.2018.6288.
    PubMed     Text format     Abstract available


  109. ZENG X, Chen S, Lin Y, Ke Z, et al
    Acylated and unacylated ghrelin inhibit apoptosis in myoblasts cocultured with colon carcinoma cells.
    Oncol Rep. 2018;39:1387-1395.
    PubMed     Text format     Abstract available


  110. LIAO W, Li G, You Y, Wan H, et al
    Antitumor activity of Notch1 inhibition in human colorectal carcinoma cells.
    Oncol Rep. 2018;39:1063-1071.
    PubMed     Text format     Abstract available


    February 2018
  111. OKUGAWA Y, Yao L, Toiyama Y, Yamamoto A, et al
    Prognostic impact of sarcopenia and its correlation with circulating miR-21 in colorectal cancer patients.
    Oncol Rep. 2018 Feb 14. doi: 10.3892/or.2018.6270.
    PubMed     Text format     Abstract available


  112. LI Y, Zhao L, Zhang Y, Guan L, et al
    Downregulation of the long non-coding RNA XLOC_010588 inhibits the invasion and migration of colorectal cancer.
    Oncol Rep. 2018 Feb 12. doi: 10.3892/or.2018.6260.
    PubMed     Text format     Abstract available


  113. SHEN L, Dong X, Wang Y, Qiu L, et al
    beta3GnT8 regulates oxaliplatin resistance by altering integrin beta1 glycosylation in colon cancer cells.
    Oncol Rep. 2018 Feb 1. doi: 10.3892/or.2018.6243.
    PubMed     Text format     Abstract available


    January 2018
  114. ENDO S, Fujita M, Yamada S, Imadome K, et al
    Fra1 enhances the radioresistance of colon cancer cells to Xray or Cion radiation.
    Oncol Rep. 2018 Jan 19. doi: 10.3892/or.2018.6223.
    PubMed     Text format     Abstract available


  115. XIONG Y, Wang J, Zhu H, Liu L, et al
    Chronic oxymatrine treatment induces resistance and epithelialmesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells.
    Oncol Rep. 2018 Jan 10. doi: 10.3892/or.2018.6204.
    PubMed     Text format     Abstract available


  116. GONG H, Fang L, Li Y, Du J, et al
    miR873 inhibits colorectal cancer cell proliferation by targeting TRAF5 and TAB1.
    Oncol Rep. 2018 Jan 8. doi: 10.3892/or.2018.6199.
    PubMed     Text format     Abstract available


  117. KIM IH, Nam TJ
    Fucoidan downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6193.
    PubMed     Text format     Abstract available


  118. SHIMADA T, Tsuruta M, Hasegawa H, Okabayashi K, et al
    Heat shock protein 27 knockdown using nucleotidebased therapies enhances sensitivity to 5-FU chemotherapy in SW480 human colon cancer cells.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6180.
    PubMed     Text format     Abstract available


  119. PHILLIPS E, Horniblow RD, Poole V, Bedford M, et al
    A potential role for hepcidin in obesity-driven colorectal tumourigenesis.
    Oncol Rep. 2018;39:392-400.
    PubMed     Text format     Abstract available


  120. WOHLLEBEN G, Hauff K, Gasser M, Waaga-Gasser AM, et al
    Hypoxia induces differential expression patterns of osteopontin and CD44 in colorectal carcinoma.
    Oncol Rep. 2018;39:442-448.
    PubMed     Text format     Abstract available


  121. WANG Y, Xia C, Lun Z, Lv Y, et al
    Crosstalk between p38 MAPK and caspase-9 regulates mitochondria-mediated apoptosis induced by tetra-alpha-(4-carboxyphenoxy) phthalocyanine zinc photodynamic therapy in LoVo cells.
    Oncol Rep. 2018;39:61-70.
    PubMed     Text format     Abstract available


    December 2017
  122. ZHAO J, Xu J, Zhang R
    MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.
    Oncol Rep. 2017 Dec 5. doi: 10.3892/or.2017.6135.
    PubMed     Text format     Abstract available


  123. YANG C, Wang MH, Zhou JD, Chi Q, et al
    Upregulation of miR-542-3p inhibits the growth and invasion of human colon cancer cells through PI3K/AKT/survivin signaling.
    Oncol Rep. 2017;38:3545-3553.
    PubMed     Text format     Abstract available


    November 2017
  124. CHEN M, Lin M, Wang X
    Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
    Oncol Rep. 2017 Nov 24. doi: 10.3892/or.2017.6110.
    PubMed     Text format     Abstract available


  125. RATTANAWONG A, Payon V, Limpanasittikul W, Boonkrai C, et al
    Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6084.
    PubMed     Text format     Abstract available


  126. LIN CS, Liu LT, Ou LH, Pan SC, et al
    Role of mitochondrial function in the invasiveness of human colon cancer cells.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6087.
    PubMed     Text format     Abstract available


  127. LI J, Li X, Cen C, Ai X, et al
    The long non-coding RNA ENST00000547547 reduces 5-fluorouracil resistance of colorectal cancer cells via competitive binding to microRNA-31.
    Oncol Rep. 2017 Nov 7. doi: 10.3892/or.2017.6082.
    PubMed     Text format     Abstract available


  128. WANG D, Rai B, Qi F, Liu T, et al
    Influence of the Twist gene on the invasion and metastasis of colon cancer.
    Oncol Rep. 2017 Nov 6. doi: 10.3892/or.2017.6076.
    PubMed     Text format     Abstract available


    October 2017
  129. ZHANG Y, Guo Y, Wang M, Dong H, et al
    Quercetrin from Toona sinensis leaves induces cell cycle arrest and apoptosis via enhancement of oxidative stress in human colorectal cancer SW620 cells.
    Oncol Rep. 2017 Oct 17. doi: 10.3892/or.2017.6042.
    PubMed     Text format     Abstract available


  130. QUE K, Tong Y, Que G, Li L, et al
    Downregulation of miR-874-3p promotes chemotherapeutic resistance in colorectal cancer via inactivation of the Hippo signaling pathway.
    Oncol Rep. 2017 Oct 17. doi: 10.3892/or.2017.6041.
    PubMed     Text format     Abstract available


  131. HE PY, Yip WK, Chai BL, Chai BY, et al
    Inhibition of cell migration and invasion by miR29a3p in a colorectal cancer cell line through suppression of CDC42BPA mRNA expression.
    Oncol Rep. 2017 Oct 16. doi: 10.3892/or.2017.6037.
    PubMed     Text format     Abstract available


  132. TIAN XQ, Guo FF, Sun DF, Wang YC, et al
    Downregulation of ZNF278 arrests the cell cycle and decreases the proliferation of colorectal cancer cells via inhibition of the ERK/MAPK pathway.
    Oncol Rep. 2017 Oct 12. doi: 10.3892/or.2017.6031.
    PubMed     Text format     Abstract available


  133. LI X, Yang H, Ke J, Liu B, et al
    Smad4 re-expression increases the sensitivity to parthenolide in colorectal cancer.
    Oncol Rep. 2017;38:2317-2324.
    PubMed     Text format     Abstract available


  134. WU S, Wu F, Jiang Z
    Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer.
    Oncol Rep. 2017;38:2043-2050.
    PubMed     Text format     Abstract available


    September 2017
  135. LI K, Na K, Sang T, Wu K, et al
    The ethanol extracts of sporoderm-broken spores of Ganoderma lucidum inhibit colorectal cancer in vitro and in vivo.
    Oncol Rep. 2017 Sep 27. doi: 10.3892/or.2017.6010.
    PubMed     Text format     Abstract available


  136. LIU X, Wang Y, Zhao J
    MicroRNA337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
    Oncol Rep. 2017 Sep 25. doi: 10.3892/or.2017.5997.
    PubMed     Text format     Abstract available


  137. LI Y, Wang C, Li D, Deng P, et al
    1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice.
    Oncol Rep. 2017 Sep 13. doi: 10.3892/or.2017.5954.
    PubMed     Text format     Abstract available


  138. FEI R, Zhang Y, Wang S, Xiang T, et al
    alpha7 nicotinic acetylcholine receptor in tumor-associated macrophages inhibits colorectal cancer metastasis through the JAK2/STAT3 signaling pathway.
    Oncol Rep. 2017 Sep 4. doi: 10.3892/or.2017.5935.
    PubMed     Text format     Abstract available


    May 2017
  139. ANUPAMA S, Laha P, Sharma M, Pathak K, et al
    Pharmacokinetics, biodistribution and antitumour effects of Sclerotium rolfsii lectin in mice.
    Oncol Rep. 2017;37:2803-2810.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: